Literature DB >> 35593950

Association between TAFI and PAI-1 polymorphisms with biochemical and hemostatic parameters in polycystic ovary syndrome.

Juliane C Albuquerque1, Natalia M C Luz2, Thalles H O Ribeiro2, Luana B X Costa1, Ana L Candido2, Fernando M Reis2, Helton J Reis3, Franciele S Silva1, Ieda F O Silva1, Karina B Gomes1, Cláudia N Ferreira4,5.   

Abstract

Entities:  

Year:  2022        PMID： 35593950     DOI： 10.1007/s00404-022-06632-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


× No keyword cloud information.
  2 in total

1.  Plasminogen Activator Inhibitor-1 4G/5G Polymorphism is Associated with Reproductive Failure: Metabolic, Hormonal, and Immune Profiles.

Authors:  Maria D Salazar Garcia; Nayoung Sung; Thomas M Mullenix; Svetlana Dambaeva; Kenneth Beaman; Alice Gilman-Sachs; Joanne Kwak-Kim
Journal:  Am J Reprod Immunol       Date:  2016-05-04       Impact factor: 3.886

2.  Fibrin lysability is associated with central obesity and inflammation in women with polycystic ovary syndrome.

Authors:  Anne C M Godtfredsen; Johannes J Sidelmann; Jørgen B Gram; Marianne Andersen; Dorte Glintborg
Journal:  Acta Obstet Gynecol Scand       Date:  2020-02-11       Impact factor: 3.636
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.